Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Study Phase : Preclinical
Sponsor : Predictive Oncology
Deal Size : Undisclosed
Deal Type : Acquisition
Predictive Oncology Acquires zPREDICTA, Inc
Details : The acquisition immediately adds a new anticipated revenue stream to Predictive Oncology and contributes to the company’s larger mission of supporting the development of new cancer therapies from drug discovery through regulatory approval.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
January 12, 2021
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Highest Development Status : Preclinical
Sponsor : Predictive Oncology
Deal Size : Undisclosed
Deal Type : Acquisition